Comprehensive Landscape of RRM2 with Immune Infiltration in Pan-Cancer

As a crucial subunit of ribonucleotide reductase, RRM2 plays a significant part in DNA synthesis. This study aimed to elucidate the comprehensive landscape of RRM2 in human cancers. With different bioinformatics platforms, we investigated the expression pattern, prognostic significance, mutational l...

Full description

Bibliographic Details
Main Authors: Zijian Zhou, Qiang Song, Yuanyuan Yang, Lujia Wang, Zhong Wu
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/14/12/2938
_version_ 1797489135935553536
author Zijian Zhou
Qiang Song
Yuanyuan Yang
Lujia Wang
Zhong Wu
author_facet Zijian Zhou
Qiang Song
Yuanyuan Yang
Lujia Wang
Zhong Wu
author_sort Zijian Zhou
collection DOAJ
description As a crucial subunit of ribonucleotide reductase, RRM2 plays a significant part in DNA synthesis. This study aimed to elucidate the comprehensive landscape of RRM2 in human cancers. With different bioinformatics platforms, we investigated the expression pattern, prognostic significance, mutational landscapes, gene interaction network, signaling pathways and immune infiltration of RRM2 in tumors. We found that RRM2 expression was predominantly up-expressed in tumor tissues in most tumors. Concurrently, RRM2 expression was significantly associated with worse prognosis and tumor stage across TCGA cancers. Moreover, RRM2 high levels were critically associated with the infiltration of natural killer T cells and immune scores. RRM2 was positively related to immune checkpoints, tumor mutation burden, microsatellite instability, neoantigen, and cytotoxic T lymphocyte in several cancers, predicting effective response to immunotherapy. Meanwhile, a strong co-expression of RRM2 with immune-related genes was observed. Additionally, multiple Cox regression analysis showed that RRM2 was an independent prognostic factor in bladder cancer (BLCA). Eventually, we verified that RRM2 was overexpressed in BLCA clinical samples and cell lines. Blocking RRM2 could suppress BLCA cells’ growth and proliferation while enhancing sensitivity to cisplatin. This study provided a new perspective for understanding RRM2 in cancers and new strategies for tumor immunotherapy.
first_indexed 2024-03-10T00:13:11Z
format Article
id doaj.art-89c603be4d674f01842b31f1b6cd380c
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-10T00:13:11Z
publishDate 2022-06-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-89c603be4d674f01842b31f1b6cd380c2023-11-23T15:56:51ZengMDPI AGCancers2072-66942022-06-011412293810.3390/cancers14122938Comprehensive Landscape of RRM2 with Immune Infiltration in Pan-CancerZijian Zhou0Qiang Song1Yuanyuan Yang2Lujia Wang3Zhong Wu4Department of Urology, Huashan Hospital, Fudan University, Shanghai 200040, ChinaDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, ChinaDepartment of Urology, Huashan Hospital, Fudan University, Shanghai 200040, ChinaDepartment of Urology, Huashan Hospital, Fudan University, Shanghai 200040, ChinaDepartment of Urology, Huashan Hospital, Fudan University, Shanghai 200040, ChinaAs a crucial subunit of ribonucleotide reductase, RRM2 plays a significant part in DNA synthesis. This study aimed to elucidate the comprehensive landscape of RRM2 in human cancers. With different bioinformatics platforms, we investigated the expression pattern, prognostic significance, mutational landscapes, gene interaction network, signaling pathways and immune infiltration of RRM2 in tumors. We found that RRM2 expression was predominantly up-expressed in tumor tissues in most tumors. Concurrently, RRM2 expression was significantly associated with worse prognosis and tumor stage across TCGA cancers. Moreover, RRM2 high levels were critically associated with the infiltration of natural killer T cells and immune scores. RRM2 was positively related to immune checkpoints, tumor mutation burden, microsatellite instability, neoantigen, and cytotoxic T lymphocyte in several cancers, predicting effective response to immunotherapy. Meanwhile, a strong co-expression of RRM2 with immune-related genes was observed. Additionally, multiple Cox regression analysis showed that RRM2 was an independent prognostic factor in bladder cancer (BLCA). Eventually, we verified that RRM2 was overexpressed in BLCA clinical samples and cell lines. Blocking RRM2 could suppress BLCA cells’ growth and proliferation while enhancing sensitivity to cisplatin. This study provided a new perspective for understanding RRM2 in cancers and new strategies for tumor immunotherapy.https://www.mdpi.com/2072-6694/14/12/2938RRM2pan-cancerprognosisimmune infiltrationimmunotherapybladder cancer
spellingShingle Zijian Zhou
Qiang Song
Yuanyuan Yang
Lujia Wang
Zhong Wu
Comprehensive Landscape of RRM2 with Immune Infiltration in Pan-Cancer
Cancers
RRM2
pan-cancer
prognosis
immune infiltration
immunotherapy
bladder cancer
title Comprehensive Landscape of RRM2 with Immune Infiltration in Pan-Cancer
title_full Comprehensive Landscape of RRM2 with Immune Infiltration in Pan-Cancer
title_fullStr Comprehensive Landscape of RRM2 with Immune Infiltration in Pan-Cancer
title_full_unstemmed Comprehensive Landscape of RRM2 with Immune Infiltration in Pan-Cancer
title_short Comprehensive Landscape of RRM2 with Immune Infiltration in Pan-Cancer
title_sort comprehensive landscape of rrm2 with immune infiltration in pan cancer
topic RRM2
pan-cancer
prognosis
immune infiltration
immunotherapy
bladder cancer
url https://www.mdpi.com/2072-6694/14/12/2938
work_keys_str_mv AT zijianzhou comprehensivelandscapeofrrm2withimmuneinfiltrationinpancancer
AT qiangsong comprehensivelandscapeofrrm2withimmuneinfiltrationinpancancer
AT yuanyuanyang comprehensivelandscapeofrrm2withimmuneinfiltrationinpancancer
AT lujiawang comprehensivelandscapeofrrm2withimmuneinfiltrationinpancancer
AT zhongwu comprehensivelandscapeofrrm2withimmuneinfiltrationinpancancer